Vanguard Fiduciary Trust’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.35M Sell
1,818,058
-71,788
-4% -$55.2K ﹤0.01% 2845
2026
Q2
$1.56M Sell
1,889,846
-27,591
-1% -$26.1K ﹤0.01% 2813
2026
Q1
$1.76M Buy
+1,917,437
New +$2.32M ﹤0.01% 2635

Other funds holding LAB

Vanguard Fiduciary Trust's LAB Position: Q3 2026 in Review

Vanguard Fiduciary Trust reduced its Standard BioTools (LAB) stake by 3.8% in Q3 2026, selling an estimated $55.2K and leaving 1,818,058 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2845.

Vanguard Fiduciary Trust first reported a position in LAB in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.76M in Q1 2026. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Vanguard Fiduciary Trust held 1,818,058 shares of Standard BioTools worth $1.35M as of Q3 2026.
  • Vanguard Fiduciary Trust sold 71,788 Standard BioTools shares in Q3 2026, an estimated $55.2K.
  • Standard BioTools made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q3 2026, its #2845 holding.
  • Vanguard Fiduciary Trust first reported a position in Standard BioTools in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Fiduciary Trust's Standard BioTools position peaked at $1.76M in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q3 2026, filed 13 Nov 2026.